Oncolytics Biotech Inc. (ONCY) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of Oncolytics Biotech Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ONCY
Oncolytics Biotech Inc.
$0.59HealthcareDelayed quote: Oct 6, 2026, 12:29 PM EDT
PDSB
PDS Biotechnology Corporation
$1.07HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
Total return — ONCY vs PDSB
growth of $100 · dividends reinvested · last 10yONCY -76.8% (-13.6%/yr)PDSB -99.5% (-40.6%/yr)ONCY compounded faster over this window
Log scale — wide-divergence pair
ONCY PDSB
ONCY vs PDSB: by the numbers
- •PDSB is the larger company ($60M vs $60M market cap).
Metrics side by side
Profitability
| Metric | ONCY | PDSB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROIC | -1235.48% | -3699.99% |
Growth (annualized)
| Metric | ONCY | PDSB |
|---|---|---|
| Total return CAGR (5Y) | -21.00% | -39.13% |
Frequently asked
- How have ONCY and PDSB total returns compared?
- Over the past 10 years, ONCY delivered -12.54% and PDSB delivered -40.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.